Virus Genes

, Volume 27, Issue 3, pp 237–247 | Cite as

Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Interacts with Human Myeloid Cell Nuclear Differentiation Antigen Induced by Interferon α

  • Masaya Fukushi
  • Masaya Higuchi
  • Masayasu Oie
  • Takafumi Tetsuka
  • Francis Kasolo
  • Kouji Ichiyama
  • Naoki Yamamoto
  • Harutaka Katano
  • Tetsutaro Sata
  • Masahiro FujiiEmail author


Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpes virus type 8 (HHV-8) is tightly linked to the development of Kaposi's sarcoma, primary effusion lymphoma (PEL) and some cases of multicentric Castleman's disease. Latency-associated nuclear antigen (LANA) is one of a limited number of KSHV genes consistently expressed in these diseases as well as in KSHV-infected cell lines derived from PEL, and has been shown to play crucial role in persistence of KSHV genomes in the infected cells. In this study, we explored the cellular factors that interact with LANA using yeast two-hybrid screening, and isolated a part of gene encoding human myeloid cell nuclear differentiation antigen (MNDA). MNDA is a hematopoietic interferon-inducible nuclear proteins with a HIN-200 family member with conserved 200-amino acid repeats. Immunoprecipitation assay revealed that LANA interacted with MNDA in a mammalian embryonic kidney cell line. MNDA transcript was undetectable in three PEL cell lines by reverse-transcription polymerase chain reaction, but it was induced by interferon α (IFNα). Moreover, LANA and MNDA were co-localized in the nuclei of MNDA-expressing PEL cells. Our results suggest that LANA interacts with MNDA in KSHV-infected cells exposed to IFNα. Such interaction may modulate IFN-mediated host defense activities.

HIN-200 family genes human myeloid cell nuclear differentiation antigen (MNDA) interferon (IFN) Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) latency-associated nuclear antigen (LANA) yeast two-hybrid screening 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., and Moore P.S., Science 266, 1865-1869, 1994.Google Scholar
  2. 2.
    Moore P.S. and Chang Y., N Engl J Med 332, 1181-1185, 1995.Google Scholar
  3. 3.
    Cesarman E., Chang Y., Moore P.S., Said J.W., and Knowles D.M., N Engl J Med 332, 1186-1191, 1995.Google Scholar
  4. 4.
    Cesarman E., Moore P.S., Rao P.H., Inghirami G., Knowles D.M., and Chang Y., Blood 86, 2708-2714, 1995.Google Scholar
  5. 5.
    Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., D'Agay M.F., Clauvel J.P., Raphael M., Degos L., and Sigaux F., Blood 86, 1276-1280, 1995.Google Scholar
  6. 6.
    Boshoff C., Schulz T.F., Kennedy M.M., Graham A.K., Fisher C., Thomas A., McGee J.O., Weiss R.A., and O'Leary J.J., Nat Med 1, 1274-1278, 1995.Google Scholar
  7. 7.
    Kedes D.H., Lagunoff M., Renne R., and Ganem D., J Clin Invest 100, 2606-2610, 1997.Google Scholar
  8. 8.
    Kellam P., Boshoff C., Whitby D., Matthews S., Weiss R.A., and Talbot S.J., J Hum Virol 1, 19-29, 1997.Google Scholar
  9. 9.
    Rainbow L., Platt G.M., Simpson G.R., Sarid R., Gao S.J., Stoiber H., Herrington C.S., Moore P.S., and Schulz T.F., J Virol 71, 5915-5921, 1997.Google Scholar
  10. 10.
    Gao S.J., Kingsley L., Li M., Zheng W., Parravicini C., Ziegler J., Newton R., Rinaldo C.R., Saah A., Phair J., Detels R., Chang Y., and Moore P.S., Nat Med 2, 925-928, 1996.Google Scholar
  11. 11.
    Kedes D.H., Operskalski E., Busch M., Kohn R., Flood J., and Ganem D., Nat Med 2, 918-924, 1996.Google Scholar
  12. 12.
    Schwam D.R., Luciano R.L., Mahajan S.S., Wong L., and Wilson A.C., J Virol 74, 8532-8540, 2000.Google Scholar
  13. 13.
    Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., Parry J.P., Peruzzi D., Edelman I.S., Chang Y., and Moore P.S., Proc Natl Acad Sci USA 93, 14862-14867, 1996.Google Scholar
  14. 14.
    Ballestas M.E., Chatis P.A., and Kaye K.M., Science 284, 641-644, 1999.Google Scholar
  15. 15.
    Ballestas M.E. and Kaye K.M., J Virol 75, 3250-3258, 2001.Google Scholar
  16. 16.
    Hu J., Garber A.C., and Renne R., J Virol 76, 11677-11687, 2002.Google Scholar
  17. 17.
    Garber A.C., Shu M.A., Hu J., and Renne R., J Virol 75, 7882-7892, 2001.Google Scholar
  18. 18.
    Cotter M.A. 2nd and Robertson E.S., Virology 264, 254-264, 1999.Google Scholar
  19. 19.
    Shinohara H., Fukushi M., Higuchi M., Oie M., Hoshi O., Ushiki T., Hayashi J., and Fujii M., J Virol 76, 12917-12924, 2002.Google Scholar
  20. 20.
    Friborg J., Kong W., Hottiger M.O., and Nabel G.J., Nature 402, 889-894, 1999.Google Scholar
  21. 21.
    Garber A.C., Hu J., and Renne R., J Biol Chem 277, 27401-27411, 2002.Google Scholar
  22. 22.
    Sarid R., Wiezorek J.S., Moore P.S., and Chang Y., J Virol 73, 1438-1446, 1999.Google Scholar
  23. 23.
    Jenner R.G. and Boshoff C., Biochim Biophys Acta 1602, 1-22, 2002.Google Scholar
  24. 24.
    Hudson C.R., Bellew T., Briggs J.A., Casey S.B., and Briggs R.C., Hybridoma 7, 541-553, 1998.Google Scholar
  25. 25.
    Lengyel P., Choubey D., Li S.J., and Datta B., Semin Virol 6, 203-213, 1995.Google Scholar
  26. 26.
    Johnstone R.W. and Trapani J.A., Mol Cell Biol 19, 5833-5838, 1999.Google Scholar
  27. 27.
    Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., and Ganem D., Nat Med 2, 342-346, 1996.Google Scholar
  28. 28.
    Miller G., Heston L., Grogan E., Gradoville L., Rigsby M., Sun R., Shedd D., Kushnaryov V.M., Grossberg S., and Chang Y., J Virol 71, 314-324, 1997.Google Scholar
  29. 29.
    Arvanitakis L., Mesri E.A., Nador R.G., Said J.W., Asch A.S., Knowles D.M., and Cesarman E., Blood 88, 2648-2654, 1996.Google Scholar
  30. 30.
    Li B. and Fields S., FASEB J 7, 957-963, 1993.Google Scholar
  31. 31.
    Iwabuchi K., Li B., Bartel P., and Fields S., Oncogene 8, 1693-1696, 1993.Google Scholar
  32. 32.
    Harlow E. and Lane D., Using Antibodies, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1999.Google Scholar
  33. 33.
    D'Agostino G., Arico E., Santodonato L., Venditti M., Sestili P., Masuelli L., Coletti A., Modesti A., Picchio G., Mosier D.E., Ferrantini M., and Belardelli F., J Interferon Cytokine Res 19, 1305-1316, 1999.Google Scholar
  34. 34.
    Knipe D.M. and Howley P.M., Fields Virology, Lippincott Williams & Wilkins, Philadelphia, 2001.Google Scholar
  35. 35.
    Doggett K.L., Briggs J.A., Linton M.F., Fazio S., Head D.R., Xie J., Hashimoto Y., Laborda J., and Briggs R.C., J Cell Biochem 86, 56-66, 2002.Google Scholar
  36. 36.
    Krithivas A., Young D.B., Liao G., Greene D., and Hayward S.D., J Virol 74, 9637-9645, 2000.Google Scholar
  37. 37.
    Renne R., Barry C., Dittmer D., Compitello N., Brown P.O., and Ganem D., J Virol 75, 458-468, 2001.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Masaya Fukushi
    • 1
  • Masaya Higuchi
    • 1
  • Masayasu Oie
    • 1
  • Takafumi Tetsuka
    • 1
    • 2
  • Francis Kasolo
    • 3
  • Kouji Ichiyama
    • 3
    • 4
  • Naoki Yamamoto
    • 4
  • Harutaka Katano
    • 5
  • Tetsutaro Sata
    • 5
  • Masahiro Fujii
    • 1
    Email author
  1. 1.Division of VirologyNiigata University Graduate School of Medical and Dental SciencesNiigataJapan
  2. 2.Division of Clinical Nephrology, Rheumatology, Respiratory Medicine and Infection Control and PreventionNiigata University Graduate School of Medical and Dental SciencesNiigataJapan
  3. 3.Virology Laboratory, Department Pathology and MicrobiologyUniversity Teaching HospitalLusakaZambia
  4. 4.Department of Molecular Virology, Division of Infection and Bioresponse Graduate SchoolTokyo Medical and Dental UniversityTokyoJapan
  5. 5.Department of PathologyNational Institute of Infectious DiseasesTokyoJapan

Personalised recommendations